Skip to content

Clinical trials

Overweight trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Taiwan Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20171
20185
20191
20201
20215
20224
202310
20244
20257
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting21
Active, not recruiting4
Not yet recruiting2
Enrolling by invitation2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company12
Novo Nordisk A/S9
National Taiwan University Hospital5
AstraZeneca3
Chang Gung Memorial Hospital3
Chung Shan Medical University3
Amgen2
China Medical University Hospital2
Hoffmann-La Roche2
Mackay Medical College2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight59
Obesity50
Diabetes Mellitus, Type 28
Metabolic Syndrome6
Nutrition Disorders4
Weight Loss4
Non-alcoholic Fatty Liver Disease3
Prediabetic State3
Sleep Apnea, Obstructive3
Diabetes Mellitus2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.